Re-Engineering Clinical Trials

Best Practices for Streamlining the Development Process

Nonfiction, Health & Well Being, Medical, Reference, Research, Medical Science, Pharmacology
Cover of the book Re-Engineering Clinical Trials by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780128007907
Publisher: Elsevier Science Publication: December 16, 2014
Imprint: Academic Press Language: English
Author:
ISBN: 9780128007907
Publisher: Elsevier Science
Publication: December 16, 2014
Imprint: Academic Press
Language: English

The pharmaceutical industry is currently operating under a business model that is not sustainable for the future. Given the high costs associated with drug development, there is a vital need to reform this process in order to provide safe and effective drugs while still securing a profit. Re-Engineering Clinical Trials evaluates the trends and challenges associated with the current drug development process and presents solutions that integrate the use of modern communication technologies, innovations and novel enrichment designs. This book focuses on the need to simplify drug development and offers you well-established methodologies and best practices based on real-world experiences from expert authors across industry and academia. Written for all those involved in clinical research, development and clinical trial design, this book provides a unique and valuable resource for streamlining the process, containing costs and increasing drug safety and effectiveness.

  • Highlights the latest paradigm-shifts and innovation advances in clinical research
  • Offers easy-to-find best practice sections, lists of current literature and resources for further reading and useful solutions to day-to-day problems in current drug development
  • Discusses important topics such as safety profiling, data mining, site monitoring, change management, increasing development costs, key performance indicators and much more
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The pharmaceutical industry is currently operating under a business model that is not sustainable for the future. Given the high costs associated with drug development, there is a vital need to reform this process in order to provide safe and effective drugs while still securing a profit. Re-Engineering Clinical Trials evaluates the trends and challenges associated with the current drug development process and presents solutions that integrate the use of modern communication technologies, innovations and novel enrichment designs. This book focuses on the need to simplify drug development and offers you well-established methodologies and best practices based on real-world experiences from expert authors across industry and academia. Written for all those involved in clinical research, development and clinical trial design, this book provides a unique and valuable resource for streamlining the process, containing costs and increasing drug safety and effectiveness.

More books from Elsevier Science

Cover of the book Usability Testing Essentials by
Cover of the book Learning from Failures by
Cover of the book Recent Advances in Parkinsons Disease by
Cover of the book Treatise on Geochemistry by
Cover of the book Computer Incident Response and Forensics Team Management by
Cover of the book Modern Component Families and Circuit Block Design by
Cover of the book Digital Printing of Textiles by
Cover of the book International Review of Cell and Molecular Biology by
Cover of the book Nonlinear Diffusion of Electromagnetic Fields by
Cover of the book Friction in Textile Materials by
Cover of the book Materials in Sports Equipment by
Cover of the book Writing for Science and Engineering by
Cover of the book Overview of Industrial Process Automation by
Cover of the book Data Analytics for Intelligent Transportation Systems by
Cover of the book Auditory Physiology and Perception by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy